Embera NeuroTherapeutics
PrivateLast Round
Grant
Dec 19, 2019
Total Funding Raised
$23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Embera NeuroTherapeutics is a biotechnology company developing novel pharmaceutical treatments for addiction, including cocaine use disorder and smoking cessation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Embera NeuroTherapeutics Comparables
Compare Embera NeuroTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PleoPharma, Inc. | 81% | |
| Kinoxis Therapeutics | 79% | |
| EpiVario, Inc. | 78% |
Embera NeuroTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 19, 2019 | ||||
| Series B | Dec 19, 2019 | ||||
| Grant | Jul 26, 2016 | ||||
| Series A Extension | Apr 10, 2015 | ||||
| Series A Extension | Aug 15, 2011 | ||||
Grant | Oct 1, 2010 |
Embera NeuroTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Action to End Smoking | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 241% MoM, reaching 1K.
- May 4, 2025
Monthly visitors increased 82% MoM.
Embera NeuroTherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Embera NeuroTherapeutics's valuation, stock price, and market status.
Is Embera NeuroTherapeutics a public or private company?
Embera NeuroTherapeutics is a private company.
What is the current stock price of Embera NeuroTherapeutics?
Embera NeuroTherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Embera NeuroTherapeutics worth (valuation)?
Valuation information for Embera NeuroTherapeutics is not publicly available.
Can I buy Embera NeuroTherapeutics stock?
Embera NeuroTherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Embera NeuroTherapeutics's last funding round?
Embera NeuroTherapeutics's most recent funding round was Grant on December 19, 2019.
Who are the main investors in Embera NeuroTherapeutics?
Key investors in Embera NeuroTherapeutics include Global Action to End Smoking.
Will Embera NeuroTherapeutics IPO soon?
No public IPO plans have been announced for Embera NeuroTherapeutics.
How can I track Embera NeuroTherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Embera NeuroTherapeutics's secondary market activity and sign up for updates.